Difference between revisions of "Comment Resolutions"
Jump to navigation
Jump to search
m |
m |
||
Line 132: | Line 132: | ||
| 2023.12.13 | | 2023.12.13 | ||
| [[Media:2023_12_13_SWS BC QIBA Technical Confirmation Resolutions.xlsx | Clinically Feasible Comment Resolutions 2023-12-13]] | | [[Media:2023_12_13_SWS BC QIBA Technical Confirmation Resolutions.xlsx | Clinically Feasible Comment Resolutions 2023-12-13]] | ||
+ | |- | ||
+ | [[Media:QIBA US VBF Profile 2023-12-13-tracked-changes.pdf|US Volume Blood Flow (VBF) Profile 2023-12-13 (tracked changes)]] | ||
+ | | Consensus | ||
+ | | 2023.12.13 | ||
+ | | [[Media:2023_12_13_VBF BC QIBA Consensus Confirmation Resolutions.xlsx | Consensus Comment Resolutions 2023-12-13]] | ||
|- | |- | ||
|} | |} |
Revision as of 15:46, 14 December 2023
Comments received during Public Comment, Clinically Feasible (formerly Technical) Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.